FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W97533075> ?p ?o ?g. }

• W97533075 endingPage "464" @default.
• W97533075 startingPage "448" @default.
• W97533075 abstract "Psoriasis, one of the most common chronic skin disease, is thought to have an immunemediated pathogenesis whereby activated T cells infiltrate the dermis and stimulate cytokines, thus promoting keratinocyte proliferation. Psoriasis affects 1–3% of the world’s population. The scalp is the site of predilection for psoriasis, as 50–75% of all psoriasis individuals have scalp psoriasis sometime during their disease. Scalp psoriasis can be associated with psoriasis vulgaris (types I and II), guttate psoriasis, pustular psoriasis or erythroderma. Scalp psoriasis is characterized by sharply demarcated erythematosquamous lesions with silver-white scaling; plaques often advancing beyond the hair border onto the face and retroauricular area. Several authors have reported that chronic plaque psoriasis may impair hair growth and even result in scarring. Patients with scalp psoriasis frequently complain of pruritus and scaling. Scalp psoriasis can severely impair patient quality of life, restricting lifestyle and daily functioning. Furthermore, it is embarrassing in social settings and associated with psychological distress in many patients. Despite a vast number of therapies, scalp psoriasis remains difficult to treat. The scalp is an area relatively inaccessible because of thick scales, hair density and proximity of the sensitive facial skin. Furthermore, many topical therapy options are unpleasant to apply, resulting in decreased adherence and efficacy. Current topical treatment modalities are based on new formulations - shampoos, lotions and foams. Shampoos are safe, well-tolerated, efficacious and preferable by the patients. Active ingredients include keratolytics (e.g. salicylic acid, sulfur), tars and corticosteroids. Topical corticosteroids (e.g. clobetasol propionate shampoo) and vitamin D analogues (not available in shampoo formulation) are the drugs of choice during the induction phase, and tar-blend shampoos (and vitamin D analogues) continue to be drugs of choice for maintenance therapy. None of the preparations evaluated stands out over the others in all clinical situations and their use must therefore be individualized in each patient." @default.
• W97533075 created "2016-06-24" @default.
• W97533075 creator A5042411884 @default.
• W97533075 creator A5082474204 @default.
• W97533075 date "2012-01-01" @default.
• W97533075 modified "2023-09-27" @default.
• W97533075 title "Shampoo in the treatment of scalp psoriasis" @default.
• W97533075 cites W104726431 @default.
• W97533075 cites W151909293 @default.
• W97533075 cites W1590700846 @default.
• W97533075 cites W190047692 @default.
• W97533075 cites W190640570 @default.
• W97533075 cites W1930073633 @default.
• W97533075 cites W1977708900 @default.
• W97533075 cites W1979820900 @default.
• W97533075 cites W1990128482 @default.
• W97533075 cites W1993332563 @default.
• W97533075 cites W1993344334 @default.
• W97533075 cites W2011639154 @default.
• W97533075 cites W2019557913 @default.
• W97533075 cites W2031998019 @default.
• W97533075 cites W2049915900 @default.
• W97533075 cites W2049961763 @default.
• W97533075 cites W2053491009 @default.
• W97533075 cites W2060760501 @default.
• W97533075 cites W2062110203 @default.
• W97533075 cites W2074559113 @default.
• W97533075 cites W2077625041 @default.
• W97533075 cites W2086984576 @default.
• W97533075 cites W2092720431 @default.
• W97533075 cites W2113430650 @default.
• W97533075 cites W2154234582 @default.
• W97533075 cites W2173787089 @default.
• W97533075 cites W2405889903 @default.
• W97533075 cites W58066341 @default.
• W97533075 doi "https://doi.org/10.3920/978-90-8686-728-8_23" @default.
• W97533075 hasPublicationYear "2012" @default.
• W97533075 type Work @default.
• W97533075 sameAs 97533075 @default.
• W97533075 citedByCount "0" @default.
• W97533075 crossrefType "book-chapter" @default.
• W97533075 hasAuthorship W97533075A5042411884 @default.
• W97533075 hasAuthorship W97533075A5082474204 @default.
• W97533075 hasConcept C142362112 @default.
• W97533075 hasConcept C142724271 @default.
• W97533075 hasConcept C16005928 @default.
• W97533075 hasConcept C2778515351 @default.
• W97533075 hasConcept C2780564577 @default.
• W97533075 hasConcept C2781171460 @default.
• W97533075 hasConcept C71924100 @default.
• W97533075 hasConceptScore W97533075C142362112 @default.
• W97533075 hasConceptScore W97533075C142724271 @default.
• W97533075 hasConceptScore W97533075C16005928 @default.
• W97533075 hasConceptScore W97533075C2778515351 @default.
• W97533075 hasConceptScore W97533075C2780564577 @default.
• W97533075 hasConceptScore W97533075C2781171460 @default.
• W97533075 hasConceptScore W97533075C71924100 @default.
• W97533075 hasLocation W975330751 @default.
• W97533075 hasOpenAccess W97533075 @default.
• W97533075 hasPrimaryLocation W975330751 @default.
• W97533075 hasRelatedWork W152437768 @default.
• W97533075 hasRelatedWork W1983875672 @default.
• W97533075 hasRelatedWork W2005751631 @default.
• W97533075 hasRelatedWork W2113107530 @default.
• W97533075 hasRelatedWork W2335025811 @default.
• W97533075 hasRelatedWork W2409235485 @default.
• W97533075 hasRelatedWork W3035892675 @default.
• W97533075 hasRelatedWork W3109629157 @default.
• W97533075 hasRelatedWork W3214186490 @default.
• W97533075 hasRelatedWork W2184060645 @default.
• W97533075 isParatext "false" @default.
• W97533075 isRetracted "false" @default.
• W97533075 magId "97533075" @default.
• W97533075 workType "book-chapter" @default.